MedinCell and the project consortium members, IRD, IRSS and CIRDES, have successfully designed, tested, and confirmed with Unitaid the selection of the lead formulation. Regulatory preclinical activities are starting with the objective of a first clinical trial in 2023. MedinCell and the consortium members have conducted an in vivo proof of concept on cattle that … Continue reading MedinCell’s Long-Acting Injectable to fight Malaria ready to enter Regulatory Development